Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05349643
Title A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors AmMax Bio, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | AUS


No variant requirements are available.